Financial Architects (New Jersey)’s Sophiris Bio, Inc. SPHS Stock Holding History

Financial Architects (New Jersey)’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-800	Closed	-$1K	–	1592
2019 Q1	$1K	Hold	800	–	–	﹤0.01%	1405
2018 Q4	$1K	Hold	800	–	–	﹤0.01%	1313
2018 Q3	$2K	Hold	800	–	–	﹤0.01%	1348
2018 Q2	$2K	Hold	800	–	–	﹤0.01%	1233
2018 Q1	$2K	Hold	800	–	–	﹤0.01%	1341
2017 Q4	$2K	Hold	800	–	–	﹤0.01%	1437
2017 Q3	$2K	Hold	800	–	–	﹤0.01%	1438
2017 Q2	$2K	Buy	800 +300	+60%	+$735	﹤0.01%	1464
2017 Q1	$1K	Hold	500	–	–	﹤0.01%	1555
2016 Q4	$1K	Hold	500	–	–	﹤0.01%	1379
2016 Q3	$2K	Buy	+500	New	+$1.88K	﹤0.01%	1385

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return

ACM

Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Financial Architects (New Jersey)'s SPHS Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 800 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in SPHS in Q3 2016 and held it in 11 quarters. The position peaked at $2K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 800 Sophiris Bio, Inc. shares in Q2 2019, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 11 quarters.
Financial Architects (New Jersey)'s Sophiris Bio, Inc. position peaked at $2K in Q3 2018.
22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.